Brainstorm Cell Theraputc (BCLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 09-2010 | 06-2010 | 03-2010 | 12-2009 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 93 | 750 | 725 | 1,215 | 1 |
| Receivables | 427 | 119 | 177 | 158 | 86 |
| Other current assets | 0 | 0 | 25 | 0 | 0 |
| TOTAL | $579 | $869 | $927 | $1,373 | $87 |
| Non-Current Assets | |||||
| PPE Net | 419 | 452 | 492 | 538 | 575 |
| Other Non-Current Assets | 91 | 62 | 56 | 81 | 95 |
| TOTAL | $510 | $514 | $548 | $619 | $670 |
| Total Assets | $1,089 | $1,383 | $1,475 | $1,992 | $757 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 137 | 41 | 1 | 9 | 370 |
| Accounts payable and accrued liabilities | 838 | 1,868 | 1,862 | 1,863 | 2,018 |
| Accrued Expenses | 448 | N/A | N/A | N/A | N/A |
| TOTAL | $1,423 | $1,909 | $1,863 | $1,872 | $2,388 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 125 | 97 | 82 | 117 | 112 |
| TOTAL | $125 | $97 | $82 | $117 | $112 |
| Total Liabilities | $1,548 | $2,006 | $1,945 | $1,989 | $2,500 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 526 | 411 | 406 | 398 | 390 |
| Common Shares | 5 | 5 | 5 | 5 | 4 |
| Retained earnings | -40,160 | -39,674 | -38,970 | -38,356 | -37,741 |
| TOTAL | $-459 | $-623 | $-470 | $3 | $-1,743 |
| Total Liabilities And Equity | $1,089 | $1,383 | $1,475 | $1,992 | $757 |